Cargando…
The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
BACKGROUND: The clinical development of new drugs with radiation appears to be limited. We hypothesised that phase I clinical trials with radiation therapy (RT) are initiated too late into a new drug's lifetime, impeding the ability to complete RT–drug development programmes before patent expir...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183859/ https://www.ncbi.nlm.nih.gov/pubmed/25117813 http://dx.doi.org/10.1038/bjc.2014.448 |